Table 5. Changes in anthropometric parameters in the GCL2505-supplemented (N=69) and placebo (N=68) groups during the treatment period.
| Treatment period |
Time × group a | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 week |
4 weeks |
8 weeks |
12 weeks |
|||||||
| Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | |||
| Weight (kg) | GCL2505 | 75.0 | 73.1, 77.0 | 75.5 | 73.5, 77.6 | 75.2 | 73.2, 77.2 | 75.0 | 72.9, 77.0 | 0.772 |
| Placebo | 74.9 | 72.8, 76.9 | 75.5 | 73.5, 77.5 | 75.0 | 73.0, 77.0 | 74.8 | 72.8, 76.8 | ||
| BMI (kg/m2) | GCL2505 | 26.8 | 26.5, 27.2 | 27.0 | 26.6, 27.4 | 26.9 | 26.5, 27.3 | 26.8 | 26.4, 27.2 | 0.731 |
| Placebo | 26.9 | 26.5, 27.3 | 27.2 | 26.8, 27.5 | 27.0 | 26.6, 27.3 | 26.9 | 26.5, 27.3 | ||
| WHR | GCL2505 | 0.95 | 0.94, 0.95 | 0.95 | 0.94, 0.96 | 0.95 | 0.94, 0.96 | 0.95 | 0.94, 0.96 | 0.807 |
| Placebo | 0.94 | 0.94, 0.95 | 0.95 | 0.94, 0.96 | 0.95 | 0.94, 0.96 | 0.95 | 0.94, 0.96 | ||
Values are means and 95% confidence intervals (CIs). WHR: waist to hip ratio.
ap-value represented as a group-by-time interaction effect using two-factor repeated-measures ANOVA.